SCNT is an advanced technique that has been successfully used in the animal system for cloning. Currently, the successful derivation of human embryonic stem cell line from SCNT has not been reported. At the Center, scientists are trying to use this technology to derive patient specific human embryonic stem cell lines that can be used to treat and cure diseases without immuno-rejection. The scientists and faculty members who teach this course have been successful in the animal system and are trying to optimize this technique in humans. In parallel to our on-going research, we provide individuals or groups an opportunity to learn this cutting-edge technology, via lectures and hands-on experience, so that they can have a glimpse into the future of therapeutic cloning and contribute to the field.
In addition, we provide training to those who wish to learn the techniques of deriving induced pluripotent stem (iPS) cells from either stemcell-derived fibroblasts or adult human skin fibroblasts.
This class is offered by special request and acceptance is based on space availability and the interest of the faculty. Please contact us if you are interested in learning these techniques.